Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.39 |
| ▸ | CDC25A | P30304 | 2/20 | 0.34 |
| ▸ | CDC25B | P30305 | 2/20 | 0.34 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.32 |
| ▸ | PGD | P52209 | 1/20 | 0.31 |
| ▸ | FBP1 | P09467 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2034053 | 0.85 | BTN3A1 (0.50) | BTN3A1 | |
| SCHEMBL4946200 | 0.83 | BTN3A1 (0.40) | BTN3A1 | |
| SCHEMBL2978878 | 0.83 | BTN3A1 (0.33) | BTN3A1 | |
| SCHEMBL2034253 | 0.83 | BTN3A1 (0.47) | BTN3A1 | |
| SCHEMBL4946206 | 0.81 | BTN3A1 (0.39) | BTN3A1 | |
| SCHEMBL2978877 | 0.79 | BTN3A1 (0.37) | BTN3A1 | |
| SCHEMBL2996800 | 0.75 | BTN3A1 (0.47) | LPAR3LPAR2LPAR1BTN3A1 | |
| SCHEMBL3005883 | 0.74 | BTN3A1 (0.46) | LPAR3LPAR2LPAR1BTN3A1 | |
| SCHEMBL2995236 | 0.73 | BTN3A1 (0.45) | LPAR3LPAR2LPAR1BTN3A1 | |
| SCHEMBL2999226 | 0.73 | BTN3A1 (0.45) | LPAR3LPAR2LPAR1BTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113842459-B | Inhibitor for pathological angiogenesis and application thereof | 陈晓文 | 2023-01-06 | — | — | CN | disclosed |
| CN-113842459-A | Inhibitor for pathological angiogenesis and application thereof | 陈晓文 | 2021-12-28 | — | — | CN | disclosed |